Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "innovation" return 65 results.
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >
7,8 billion forint (€ 25m) investment will significantly increase production at its Budapest Campus
Ceva shines light on the future with focus on innovation during VIV Asia 2017 >
Ceva’s teams brought innovation to the fore during VIV Asia 2017
Ceva reinforces its position in China and swine through new joint-venture with EBVAC >
In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new busin...
Ceva stresses the need for continued innovation to ensure effective disease control at IPPE 2017 >
Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.
Ceva acquires Hertape and Inova to enter Brazil’s top 5 animal health companies >
Move will increase the group global vaccine footprint with significant entry into the ruminant, Foot and Mouth disease market and a first entry into companion animal vaccines.
C.H.I.C.K Program receives the 1st independently audited quality recognition >
For the first time, an AH company services program receives internationally recognized quality approval from Bureau Veritas.
Ceva sponsors the International Symposium on Marek’s Disease and Avian Herpes viruses organised by INRA, France >
11th International Symposium on Marek’s Disease and Avian Herpes viruses organized in Tours, France